Mreg Activity in Tumor Response to Photodynamic Therapy and Photodynamic Therapy-Generated Cancer Vaccines
Open Access
Abstract
Myeloid regulatory cells (Mregs) are, together with regulatory T cells (Tregs), a dominant effector population responsible for restriction of the duration and strength of antitumor immune response. Photodynamic therapy (PDT) and cancer vaccines generated by PDT are modalities whose effectiveness in tumor destruction is closely dependent on the associated antitumor immune response. The present study investigated whether the immunodepletion of granulocytic Mregs in host mice by anti-GR1 antibody would improve the response of tumors to PDT or PDT vaccines in these animals. Anti-GR1 administration immediately after Temoporfin-PDT of mouse SCCVII tumors abrogated curative effect of PDT. The opposite effect, increasing PDT-mediated tumor cure-rates was attained by delaying anti-GR1 treatment to 1 h post PDT. With PDT vaccines, multiple anti-GR1 administrations (days 0, 4, and 8 post vaccination) improved the therapy response with SCCVII tumors. The results with PDT suggest that neutrophils (boosting antitumor effect of this therapy) that are engaged immediately after photodynamic light treatment are within one hour replaced with a different myeloid population, presumably Mregs that hampers the therapy-mediated antitumor effect. Anti-GR1 antibody, when used with optimal timing, can improve the efficacy of both PDT of tumors in situ and PDT-generated cancer vaccines.Keywords
Funding Information
- Canadian Cancer Society (701132)
This publication has 30 references indexed in Scilit:
- Immunoregulatory Cell Depletion Improves the Efficacy of Photodynamic Therapy-Generated Cancer VaccinesInternational Journal of Molecular Sciences, 2015
- Calreticulin as Cancer Treatment Adjuvant: Combination with Photodynamic Therapy and Photodynamic Therapy-Generated VaccinesFrontiers in Oncology, 2015
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Interleukin-6 Induces Gr-1+CD11b+ Myeloid Cells to Suppress CD8+ T Cell-Mediated Liver Injury in MicePLOS ONE, 2011
- Photodynamic Therapy-Generated Cancer Vaccines2010
- Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor ImmunosurveillanceJournal of Experimental Medicine, 2003
- Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumoursPhotochemical & Photobiological Sciences, 2002
- Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapyHead & Neck, 2001
- Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo.1996
- Inhibition of tumor growth by elimination of granulocytes.Journal of Experimental Medicine, 1995